Takeda-backed Ascentage Pharma files for $100M IPO
Takeda-backed Ascentage Pharma Group (AAPG) has filed to raise up to $100M through a U.S. initial public offering.
The Chinese drug developer didn’t specify terms in its SEC filing, but indicated in a filing fee schedule that it was looking